期刊文献+

术前TSH水平与甲状腺结节恶性风险的相关性 被引量:5

Correlation between preoperative thyroid stimulating hormone level and the malignant risk of thyroid nodules
原文传递
导出
摘要 目的探究术前TSH水平与甲状腺结节恶性风险的相关性。方法回顾性分析959例甲状腺结节患者的病例资料,通过SPSS 17.0软件进行统计学分析。结果 959例患者中,良性结节组746例,甲状腺乳头状癌(PTC)组213例。PTC患者术前的血清TSH水平高于良性结节患者[(2.32±1.65)mU/L比(1.76±1.20)mU/L,P<0.001],并随TSH水平上升,PTC的患病风险增加。术前TSH水平与PTC肿瘤直径、病灶数量和淋巴结转移情况无相关性(P>0.05)。logistic回归分析结果显示,术前TSH水平是PTC发生的独立影响因素[OR=1.315,95%CI为(1.171,1.477),P<0.001]。TSH诊断PTC的最佳临界值为1.575 mU/L,此时灵敏度为62.0%,特异度为53.4%,受试者工作特征(ROC)曲线下面积为0.602(P<0.001)。结论术前TSH水平与甲状腺结节恶性风险有一定的相关性,随TSH水平的上升PTC的患病风险增加。 Objective To study the correlation between preoperative serum thyroid stimulating hormone (TSH) level and the malignant risk of thyroid nodules. Methods This study retrospectively analyzed the medical records of 959 patients with thyroid nodules. Ststistical analysis was conducted by SPSS 17.0 software. Results There were 959 patients with thyroid nodules, of which 746 cases were benign, and 213 cases were diagnosed as thyroid papillary carcinoma (PTC). The preoperative TSH level of PTC patients was higher than that with benign nodules [(2.32±1.65) mU/L vs. (1.76±1.20) mU/L, P〈0.001]. Moreover, the higher preoperative TSH level was, the higher risk of diagnosed as PTC would be. There was no correlation between the preoperative TSH level and tumor diameter, number of lesions, and lymph nodes metastasis in PTC (P〉0.05). Logistic regression analysis showed that, the preoperative TSH level was an independent risk factor for PTC [OR=1.315, 95% CI was (1.171, 1.477), P〈0.001]. The best critical value of TSH in the PTC diagnosis was 1.575 mU/L. At this point, the sensitivity was 62.0%, the specificity was 53.4%, and the area under the receiver operating characteristic (ROC) curve was 0.602 (P〈0.001). Conclusion There is a certain correlation between preoperative TSH level and malignant risk of thyroid nodules, and the risk increases with the raise of preoperative TSH level.
作者 宋春峰 刘满想 倪传斗 杨明军 邢鹏 张巍 SONG Chunfeng;LIU Manxiang;NI Chuandou;YANG Mingjun;XING Peng;ZHANG Wei(Department of Hepatobiliary Surgery,General Hospital of Shenyang Military Command,Shenyang 110000,P.R.China;The First Clinical Medical College,Lanzhou University,Lanzhou 73000,P.R.China)
出处 《中国普外基础与临床杂志》 CAS 2018年第9期1060-1064,共5页 Chinese Journal of Bases and Clinics In General Surgery
基金 国家自然科学基金青年基金(项目编号:31401215) 辽宁省自然科学基金面上项目(项目编号:2015020401) 中国博士后科学基金面上项目(项目编号:2015M582884)
关键词 甲状腺结节 促甲状腺激素 甲状腺乳头状癌 thyroid nodule thyroid stimulating hormone thyroid papillary carcinoma
  • 相关文献

参考文献4

二级参考文献41

  • 1滕卫平,邢小平,童南伟,等.中国十城市甲状腺疾病流行病学调查[C].中华医学会第九次全国内分泌学学术会议论文汇编.北京:中华医学会,2010:11.
  • 2American Cancer Society. Cancer facts and figures 20(18[R]. Atlanta: American Cancer Society, 21108.
  • 3Mitchell h Livingston EH, Chang AY, et al. Trends in thyroid cancer demographics and surgical therapy in the United States [J]. Surgery, 2007,42 (6) .. 823-8.
  • 4Ji B, Wang GY, Zhang P, et al. Relationship between COX-2 and VEGF expression in thyroid cancer and angiogenesis and clinical pathology [J]. Jilin Da Xue Xue Bao(Yi Xue Ban), 2006,32(6): 1077-80.
  • 5Fenton C,Patel A,D:nauer C,et al. The Expression of Vascu- lar Endothelial Growth Factor and the Type 1 Vascular Endo- thelial Growth Factor Receptor Correlate with the Size of Pa- pillary Thyroid Carcinoma in Children and Young Adults[J], Thyroid, 2000,10 (4) : 349-57.
  • 6Klein M, Vignaud JM, Hennequin V, et al. Increased expres- sion of the vascular endothelial growth factor is a pejorative prognosis marker in papillary thyroid carcinoma [J]. J Clin En- docrinol Metab, 2001, B6 (2) : 656-8.
  • 7Lennard CM,Patel A,Wilson J,et al. Intensity of vascular en- dothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papilla- ry thyroid cancer[J]. Surgery, 2001,129 (5) : 552-8.
  • 8Boelaert K, Horacek J, Holder RL, et al. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine- needle aspiration[J]. J Clin Endo- crinol Metab, 2006,91 ( 11 ) : 4295-301.
  • 9Haymart MR, Repplinger DJ, Leverson GE,et al. Higher ser- um thyroid stimulating hormone level in thyroid nodule pa- tients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage[J]. J Clin Endocrinol Metab,2008,93(3) :809-14.
  • 10Shi LF,Guan HX,Li YS,et al. The relationship between Pre- operative serum thyroid-stimulating hormone level and thyroid nodule [J]. Zhonghua Nei Fen Mi Dai Xie Za Zhi,2010,26(3) : 213-4.

共引文献65

同被引文献75

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部